Survodutide Research# Key trials include the obesity Phase 2 (Lancet Diabetes & Endocrinology, 2024, 18.7% weight loss), MASH Phase 2 (NEJM, 2024, 62% MASH resolution), SYNCHRONIZE-1/2 (Phase 3, obesity, fully enrolled), and LIVERAGE (Phase 3, MASH, ongoing)
Its reducing obesity-related disease and improving long-term health. Results from an earlier retatrutide trial, TRIUMPH-1 which helped some adults lose as much as 30 percent of their starting body weight have got people talking, says Mir Ali, MD, the medical director of MemorialCare Surgical Weight Loss Center at Orange Coast Medical Center in Fountain Valley, California
the genuinely mixed VitaMIND and Finnish Vitamin D supplementation trials
Beginning GLP-1s Set up nutrition and training that work with the medication from day one, so the weight you lose is fat, not muscle